Key statistics
On Friday, Omeros Corp (0KBU:LSE) closed at 11.95, -37.04% below its 52-week high of 18.98, set on Jan 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 11.95 |
| Low | 11.95 |
| Bid | -- |
| Offer | -- |
| Previous close | 11.51 |
| Average volume | 1.30k |
|---|---|
| Shares outstanding | 70.90m |
| Free float | 68.92m |
| P/E (TTM) | -- |
| Market cap | 828.83m USD |
| EPS (TTM) | -2.04 USD |
Data delayed at least 20 minutes, as of Feb 13 2026 18:13 GMT.
More ▼
Press releases
- Omeros Announces First Commercial Sales of YARTEMLEA®
- Omeros Announces New Date for YARTEMLEA® Approval Conference Call
- FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
- Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
